Andrew Ross Nager

Title: The Innovations of Andrew Ross Nager

Introduction

Andrew Ross Nager is an accomplished inventor based in Mountain View, California. He is known for his significant contributions to the field of immunology, particularly through his innovative patent related to chimeric cytokine receptors. His work aims to enhance the functional activities of genetically modified immune cells, which has important implications for therapeutic applications.

Latest Patents

Nager holds a patent for "Inducible chimeric cytokine receptors." This invention provides inducible chimeric cytokine receptors that are responsive to a ligand, such as a small molecule or protein. The patent outlines the uses of these receptors for improving the functional activities of genetically modified immune cells, specifically T cells, that comprise the inducible chimeric cytokine receptors. Additionally, it includes compositions that feature such cells, showcasing the potential for advancements in immune therapies.

Career Highlights

Andrew Ross Nager is currently associated with Allogene Therapeutics, Inc., where he continues to push the boundaries of immunotherapy. His work at the company focuses on developing innovative solutions that leverage the power of genetically modified immune cells to combat various diseases.

Collaborations

Nager collaborates with talented individuals in his field, including Spencer Park and Javier Fernando Chaparro Riggers. These partnerships enhance the research and development efforts at Allogene Therapeutics, Inc., fostering an environment of innovation and discovery.

Conclusion

Andrew Ross Nager's contributions to the field of immunology through his patent on inducible chimeric cytokine receptors exemplify the impact of innovative thinking in medicine. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.